Colon cancer is the 2nd leading cause of cancer-related death in the U.S., but more than 90% of colon cancer cases can be prevented by routine screenings1.
In support of Colon Cancer Awareness Month, Boston Scientific will donate 1% of Colonic Stent, Snare, Clip and Biopsy Forceps sales made in March to the Colon Cancer Alliance, a non-profit organization dedicated to knocking colon cancer out of the top three cancer killers by championing prevention, funding cutting-edge research and providing patient support services.
Boston Scientific will donate 1% of product sales during the month of March to the Colon Cancer Alliance, with a maximum donation amount of $75,000. This program applies to WallFlex™ Colonic Stents, Resolution™ Clips, Radial Jaw™ Biopsy Forceps, Captivator™ Snares, Sensation™ Snares, Captiflex™ Snares and Profile™ Snares sold from March 1-31, 2016. The Program is subject to modification or termination by Boston Scientific without prior notification. This program may not be available in all countries. Contact your Territory Manager for details of the Program.
The Blue Hope Prevention Award provides qualifying individuals with access to lower cost screening, or stipends to reduce the costs associated with screening. Boston Scientific is a proud partner of the Colon Cancer Alliance and founding sponsor of the Blue Hope Prevention award.Learn More
Sales Supporting Pancreatic Cancer Research
Boston Scientific Corporation donated $75,000 of global Expect™ Needle and WallFlex™ Biliary RX Stent sales made in November 2015 to The Lustgarten Foundation to support pancreatic cancer research.